Single-use Assemblies Market Analysis & Forecast To 2030 By Key Players, Share, Trend, Segmentation
Global Single-Use
Assemblies Market Overview
The Global Single-Use
Assemblies Market, valued at USD 2.25 billion, is projected to
expand at a robust CAGR of 22% through 2026. Market growth is driven by
the increasing adoption of ready-to-use single-use assemblies, strong funding
support for the development of single-use technologies, the expanding biologics
and vaccines market, and rising investments in biopharmaceutical R&D.
Single-use assemblies
are custom-engineered, ready-to-use systems composed of multiple plastic
components configured into a unified, sterile solution based on specific
process requirements. These assemblies play a crucial role in modern
bioprocessing, offering flexibility, sterility, and operational efficiency
compared to traditional stainless-steel systems.
Download Sample
Copy: https://meditechinsights.com/single-use-assemblies-market/request-sample/
Key Advantages
Driving Market Growth
Traditionally,
bioprocessing end users have performed in-house assembly of single-use systems,
which often increases the risk of improper connections, leakage, and
cross-contamination—leading to costly production delays. In contrast,
pre-assembled single-use systems mitigate these risks by providing
standardized, sterile, and quality-controlled solutions.
Major advantages of
single-use assemblies include:
- Faster integration of single-use
components within bioprocess workflows
- Lower risk of contamination and system
leakage
- Reduced labor, material, and operational
costs
- Elimination of cleaning requirements and
downtime
- Significant savings in water and energy
consumption
- Improved documentation and quality control
- Enhanced overall process efficiency
Growing Funding
Support Accelerates Market Expansion
The increasing
preference for disposable and flexible production systems has led nearly every
sterile manufacturing segment to transition toward single-use alternatives.
These systems substantially reduce facility setup and cleaning costs, minimize
batch contamination risks, and enhance production agility—key benefits driving
widespread adoption.
Governmental and
institutional funding initiatives are further boosting production capabilities
across the sector.
Notable examples
include:
- High Purity New England received a USD 15 million grant
(January 2022) from the Biomedical Advanced Research and
Development Authority (BARDA) to expand production of single-use
assemblies, pumps, and sterile packaged components.
- Meissner Filtration Products secured a USD 13.4 million BARDA
contract (April 2021) to accelerate the manufacturing capacity of
single-use systems vital for COVID-19 vaccine and therapeutic production.
“Single-use assemblies
deliver everything bioprocessors need—from bags and connectors to filters and
tubing—enabling flexible and scalable manufacturing for a wide range of
therapies. They are essential to the global vaccine and biologics supply
chain.”
— Senior Director, Leading Single-use Assembly Manufacturer, United States
Market Challenge:
Risk of Leachables
Despite their
advantages, leachables remain a key concern in the use of single-use systems.
These are chemical compounds that may migrate from plastic or elastomeric
components into drug formulations during processing or storage. The presence of
leachables can compromise drug purity, product quality, and patient safety.
To address this
challenge, industry stakeholders are implementing:
- Comprehensive extractables and leachables
studies
- Risk-based assessments and toxicological
evaluations
- Adoption of standardized characterization
protocols
- Collaborative guidance development between
suppliers and end users
Such proactive
measures are expected to mitigate contamination risks and sustain the long-term
adoption of single-use technologies across the biopharmaceutical sector.
Competitive
Landscape
The global single-use
assemblies market is characterized by the presence of several established
players competing through technological innovation, capacity expansion, and
strategic partnerships. Leading companies include:
- Thermo Fisher Scientific, Inc.
- Sartorius Stedim Biotech
- Danaher Corporation
- Merck KGaA
- Avantor, Inc.
- Saint-Gobain
- and other emerging regional manufacturers.
Browse Report: https://meditechinsights.com/single-use-assemblies-market/
About Medi-Tech
Insights
Medi-Tech Insights is
a healthcare-focused business research & insights firm. Our clients include
Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We
have completed 100+ projects in Digital Health, Healthcare IT, Medical Technology,
Medical Devices & Pharma Services in the areas of market assessments, due
diligence, competitive intelligence, market sizing and forecasting, pricing
analysis & go-to-market strategy. Our methodology includes rigorous
secondary research combined with deep-dive interviews with industry-leading
CXO, VPs, and key demand/supply side decision-makers.
Comments
Post a Comment